Quratis Inc. Logo

Quratis Inc.

Develops infectious disease vaccines and offers biologics CDMO services for global health.

348080 | KO

Overview

Corporate Details

ISIN(s):
KR7348080003
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 의료단지길 143 -, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Quratis Inc. is a biopharmaceutical company specializing in the development of innovative vaccines for infectious diseases and providing advanced biologics manufacturing services. The company's R&D pipeline focuses on next-generation vaccines for global health threats, including tuberculosis (TB), COVID-19, and other neglected tropical diseases. In addition to its proprietary development, Quratis operates as a Contract Development and Manufacturing Organization (CDMO), leveraging its state-of-the-art GMP-certified facilities. It offers comprehensive bench-to-field support, from research and process optimization to commercial-scale production, with expertise in platforms such as mRNA-LNP drug delivery. Through strategic global partnerships, Quratis aims to deliver high-quality, accessible, life-saving solutions worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 179.5 KB
2025-06-19 00:00
Regulatory News Service
신규시설투자등
Korean 7.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-09 00:00
Regulatory News Service
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Korean 4.7 KB
2025-05-08 00:00
Regulatory News Service
조회공시요구(현저한시황변동)
Korean 3.5 KB
2025-05-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 183.5 KB
2025-04-17 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.6 MB
2025-04-08 00:00
Annual Report
[기재정정]사업보고서 (2023.12)
Korean 1.5 MB
2025-04-07 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 492.3 KB
2025-04-07 00:00
Audit Report / Information
감사보고서제출
Korean 19.1 KB
2025-04-07 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 31.5 KB
2025-04-07 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 36.6 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.7 KB

Automate Your Workflow. Get a real-time feed of all Quratis Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Quratis Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Quratis Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ODI Pharma AB Logo
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
Sweden
ODI
Olema Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing targeted therapies for women's cancers, focusing on breast cancer.
United States of America
OLMA
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea
226950
OMEROS CORP Logo
Develops first-in-class therapeutics for challenging diseases with unmet medical needs.
United States of America
OMER
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France
ALONC
Oncodesign Precision Medicine S.A Logo
Develops precision therapies & diagnostics for resistant and metastatic cancers.
France
ALOPM
Oncoinvent ASA Logo
Developing alpha-emitting radiotherapies for treating cancers in the peritoneal cavity.
Norway
OCIN
Oncolys BioPharma Inc. Logo
Developing oncolytic virus therapies and diagnostics for cancer and serious viral infections.
Japan
4588
ONCOLYTICS BIOTECH INC Logo
Developing an immuno-oncolytic virus to treat breast and gastrointestinal cancers.
United States of America
ONCY
Onconetix, Inc. Logo
Develops diagnostics and therapeutics for men's health and oncology markets.
United States of America
ONCO

Talk to a Data Expert

Have a question? We'll get back to you promptly.